Tag: Obesity
Global obesity rate surpasses 1 billion, WHO study reveals
by Editor | Mar 2, 2024 | LATEST NEWS, WORLD NEWS | 0
USA— A recent study published in The Lancet reveals alarming trends in global obesity, indicating...
Read MoreAmgen’s breakthrough obesity drug AMG 133 sparks investor frenzy
by Editor | Feb 9, 2024 | LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0
During Amgen’s recent fourth-quarter earnings call conference on Tuesday, February 6, Wall Street analysts were enthusiastic about the prospects of AMG 133, an experimental GLP-1 drug intended for the treatment of obesity.
Read MoreNovo Nordisk partners with Omega Therapeutics and Cellarity
by Editor | Jan 9, 2024 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
DENMARK – Novo Nordisk has inked separate research collaboration agreements with Omega...
Read MoreRoche ventures into lucrative weight-loss market with US$2.7 billion Carmot Therapeutics merger
by Editor | Dec 5, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SWITZERLAND — Swiss pharmaceutical giant Roche has strategically entered the competitive...
Read MoreNovo Nordisk sues Wells Pharmacy Network over semaglutide compounded drugs
by Editor | Dec 1, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Novo Nordisk has filed a lawsuit against Wells Pharmacy Network, alleging misleading...
Read MorePfizer halts twice-daily Danuglipron study due to side effects, shifts focus to once-daily version
by Editor | Dec 1, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA — Pharmaceutical giant Pfizer has abandoned the development of the twice-daily version of its...
Read MoreNovo Nordisk explores flexible pricing options for weight-loss drug Wegovy
by Editor | Nov 30, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
DENMARK — Novo Nordisk CEO, Lars Fruergaard Jørgensen, has announced that the Danish...
Read MoreNovo Nordisk invests US$2.3 billion in French facility to meet high demand for weight-loss and diabetes drugs
by Editor | Nov 26, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
FRANCE – Danish pharmaceutical giant Novo Nordisk has unveiled a substantial US$2.3 billion...
Read MorePharmaceutical giants capitalize on soaring obesity rates with revolutionary weight-loss drugs
by Editor | Nov 20, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Obesity rates in the United States have witnessed a relentless ascent for well over a...
Read MorePharma giants Eli Lilly and Novo Nordisk drive retail investor interest amid weight-loss drug success
by Editor | Nov 19, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Retail investor interest in Eli Lilly has soared to a more than two-year high following the...
Read MoreEli Lilly bolsters manufacturing efforts with multi-billion investment in German plant
by Editor | Nov 17, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
GERMANY – Eli Lilly, a leading pharmaceutical company, is intensifying its manufacturing efforts...
Read MoreBelgium contemplates temporarily banning Novo Nordisk’s Ozempic
by Editor | Nov 15, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
BELGIUM — Belgium is deliberating on a temporary ban on Novo Nordisk’s diabetes treatment,...
Read More